TIMI flow grade 0: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 13: | Line 13: | ||
==Additional Examples== | ==Additional Examples== | ||
[[TIMI flow grade 0 case studies| | Click [[TIMI flow grade 0 case studies|here]] for other examples of TIMI flow grade 0. | ||
==References== | ==References== | ||
Revision as of 14:58, 6 September 2013
|
WikiDoc Resources for TIMI flow grade 0 |
|
Articles |
|---|
|
Most recent articles on TIMI flow grade 0 Most cited articles on TIMI flow grade 0 |
|
Media |
|
Powerpoint slides on TIMI flow grade 0 |
|
Evidence Based Medicine |
|
Cochrane Collaboration on TIMI flow grade 0 |
|
Clinical Trials |
|
Ongoing Trials on TIMI flow grade 0 at Clinical Trials.gov Trial results on TIMI flow grade 0 Clinical Trials on TIMI flow grade 0 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on TIMI flow grade 0 NICE Guidance on TIMI flow grade 0
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on TIMI flow grade 0 Discussion groups on TIMI flow grade 0 Patient Handouts on TIMI flow grade 0 Directions to Hospitals Treating TIMI flow grade 0 Risk calculators and risk factors for TIMI flow grade 0
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for TIMI flow grade 0 |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Definition
No perfusion. No antegrade flow beyond the point of occlusion.[1] [2] [3]
Example
Shown below are an animated image and a static image depicting TIMI flow grade 0 in the RCA. Outlined in blue in the second image is the flow of the dye which completely stops at the level of the stenosis. Outlined with a yellow dashed line is the pathway that the dye would have filled in case the stenosis was absent.
Additional Examples
Click here for other examples of TIMI flow grade 0.
References
- ↑ Gibson, CM; Ryan, K; Sparano, A; Rizzo, M; Moynihan, J; Kelley, M; Marble, SJ; Dodge, JT; Antman, EM. Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. Am Heart J. 1999;137:1179–1184. PMID 10347349
- ↑ Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996 Mar 1;93(5):879-88. PMID 8598078
- ↑ Gibson CM, Murphy S, Menown IB, Sequeira RF, Greene R, Van de Werf F, Schweiger MJ, Ghali M, Frey MJ, Ryan KA, Marble SJ, Giugliano RP, Antman EM, Cannon CP, Braunwald E. Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1999 Nov 1;34(5):1403-12. PMID 10551685